CLEVELAND, Ohio — More people are taking GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight and control Type 2 ...

The FDA approved a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight with weight-related ...

ATTAIN demonstrated placebo-adjusted weight reductions of roughly 9–11 percentage points at 72 weeks, with 27.3 lb (12.4%) ...

GLP-1 weight-loss drug Wegovy has a lower, flat monthly price for patients who use a new subscription program for the ...

Lexaria Bioscience Corp. (NASDAQ: LEXX) on Tuesday provided an update on its Phase 1b, 12-week chronic study GLP-1-H24-4, recently completed in Australia, focusing on 4 DehydraTECH ( DHT) study arms ...

The icon, who has cowritten a new book on obesity, tells PEOPLE she 'tried to beat the medication' In 2023, Oprah Winfrey revealed that she was taking GLP-1 weight loss medication, telling PEOPLE the ...

GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...

You’ve heard of the rise of “Ozempic babies” — where women who’ve previously struggled with infertility get knocked up on GLP-1s — but new research shows that going off those drugs may have a negative ...

Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the multibillion-dollar market ...

This is read by an automated voice. Please report any issues or inconsistencies here. My friend Sara, eight weeks after giving birth, left me a tearful voicemail. I’m a clinical psychologist ...

Add Yahoo as a preferred source to see more of our stories on Google. More than 12% of Americans have used a GLP-1 medications for weight loss, according to a KFF (formerly Kaiser Family Foundation) ...